Consulting firm GfK Bridgehead (formerly Bridgehead International) provides a bridge to commercialization for pharmaceutical and medical device companies. Its transaction support division offers technical and commercial advice to firms developing new health care products. The market access strategy segment helps companies evaluate competitive pricing and reimbursement models, while the pricing and reimbursement unit helps clients determine pricing strategies in the marketplace. Other GfK Bridgehead services include opportunity assessment, valuation, due diligence, and health economics analysis. The company operates across Europe, Asia, and North America. Market research firm GfK acquired the company in 2012.